keyword
https://read.qxmd.com/read/38474160/curcumin-in-cancer-and-inflammation-an-in-depth-exploration-of-molecular-interactions-therapeutic-potentials-and-the-role-in-disease-management
#21
REVIEW
Dong-Oh Moon
This paper delves into the diverse and significant roles of curcumin, a polyphenolic compound from the Curcuma longa plant, in the context of cancer and inflammatory diseases. Distinguished by its unique molecular structure, curcumin exhibits potent biological activities including anti-inflammatory, antioxidant, and potential anticancer effects. The research comprehensively investigates curcumin's molecular interactions with key proteins involved in cancer progression and the inflammatory response, primarily through molecular docking studies...
March 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38472446/crosstalk-between-purinergic-receptor-p2y-11-and-chemokine-receptor-cxcr7-is-regulated-by-cxcr4-in-human-macrophages
#22
JOURNAL ARTICLE
Dominik Klaver, Hubert Gander, Beatrice Frena, Marco Amato, Martin Thurnher
P2Y11 is a G protein-coupled ATP receptor that activates IL-1 receptor (IL-1R) in a cyclic AMP dependent manner. In human macrophages, P2Y11 /IL-1R crosstalk with CCL20 as a prime target is controlled by phosphodiesterase 4 (PDE4), which mediates breakdown of cyclic AMP. Here, we used gene expression analysis to identify activation of CXCR4 and CXCR7 as a hallmark of P2Y11 signaling. We found that PDE4 inhibition with rolipram boosts P2Y11 /IL-1R-induced upregulation of CXCR7 expression and CCL20 production in an epidermal growth factor receptor dependent manner...
March 13, 2024: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/38461159/roflumilast-inhibits-tumor-growth-and-migration-in-stk11-lkb1-deficient-pancreatic-cancer
#23
JOURNAL ARTICLE
Shuman Zhang, Duo Yun, Hao Yang, Markus Eckstein, Gihan Daw Elbait, Yaxing Zhou, Yanxi Lu, Hai Yang, Jinping Zhang, Isabella Dörflein, Nathalie Britzen-Laurent, Susanne Pfeffer, Marc P Stemmler, Andreas Dahl, Debabrata Mukhopadhyay, David Chang, Hang He, Siyuan Zeng, Bin Lan, Benjamin Frey, Chuanpit Hampel, Eva Lentsch, Paradesi Naidu Gollavilli, Christian Büttner, Arif B Ekici, Andrew Biankin, Regine Schneider-Stock, Paolo Ceppi, Robert Grützmann, Christian Pilarsky
Pancreatic cancer is a malignant tumor of the digestive system. It is highly aggressive, easily metastasizes, and extremely difficult to treat. This study aimed to analyze the genes that might regulate pancreatic cancer migration to provide an essential basis for the prognostic assessment of pancreatic cancer and individualized treatment. A CRISPR knockout library directed against 915 murine genes was transfected into TB 32047 cell line to screen which gene loss promoted cell migration. Next-generation sequencing and PinAPL...
March 9, 2024: Cell Death Discovery
https://read.qxmd.com/read/38453769/targeting-aquaporin-5-by-phosphodiesterase-4-inhibition-offers-new-therapeutic-opportunities-for-ovarian-ischemia-reperfusion-injury-in-rats
#24
JOURNAL ARTICLE
Ayse Bozkurt, Zeynep Karakoy, Pelin Aydin, Bengul Ozdemir, Erdem Toktay, Zekai Halici, Elif Cadirci
This study aimed to examine the effect of Phosphodiesterase 4 (PDE4) inhibition on Aquaporin-5 (AQP5) and its potential cell signaling pathway in the ovarian ischemia reperfusion (OIR) model. Thirty adult female rats were divided into five groups: Group 1; Control: Sham operation, Group 2; OIR that 3 hour ischemia followed by 3 hour reperfusion, Group 3; OIR + Rolipram 1 mg/kg, Group 4; OIR + Rolipram 3 mg/kg, Group 5; OIR + Rolipram 5 mg/kg. Rolipram was administered intraperitoneally to the rats in groups 3-4 and 5 at determined doses 30 minutes before reperfusion...
March 7, 2024: Reproductive Sciences
https://read.qxmd.com/read/38438923/a-proof-of-concept-phase-ii-study-with-the-pde-4-inhibitor-roflumilast-in-patients-with-mild-cognitive-impairment-or-mild-alzheimer-s-disease-dementia-romema-study-protocol-of-a-double-blind-randomized-placebo-controlled-between-subjects-trial
#25
JOURNAL ARTICLE
Nina Possemis, Frans Verhey, Jos Prickaerts, Arjan Blokland, Inez Ramakers
BACKGROUND: Research into the neurobiological underpinnings of learning and memory has demonstrated the cognitive-enhancing effects associated with diverse classes of phosphodiesterase (PDE) inhibitors. Specific PDE inhibitors have been identified to improve neuronal communication through selective inhibition of PDE activity. Roflumilast, a PDE4 inhibitor, has demonstrated efficacy in enhancing episodic memory in healthy adults and elderly participants with pronounced memory impairment, indicative of amnestic mild cognitive impairment (aMCI)...
March 4, 2024: Trials
https://read.qxmd.com/read/38431099/effects-of-oral-roflumilast-therapy-on-body-weight-and-cardiometabolic-parameters-in-patients-with-psoriasis-results-from-a-randomized-controlled-trial-psorro
#26
JOURNAL ARTICLE
Mette Gyldenløve, Jennifer Astrup Sørensen, Simon Fage, Howraman Meteran, Lone Skov, Claus Zachariae, Filip Krag Knop, Mia-Louise Nielsen, Alexander Egeberg
BACKGROUND: Weight loss is reported with oral roflumilast, which is approved for chronic obstructive pulmonary disease. Recently, the drug has shown efficacy in psoriasis, a disease strongly linked to overweight/obesity. OBJECTIVE: To describe the effects of oral roflumilast on body weight and cardio-metabolic parameters in patients with psoriasis. METHODS: Post-hoc analyses from the PSORRO study, where patients with moderate-to-severe plaque psoriasis were randomized 1:1 to oral roflumilast 500 μg once-daily or placebo for 12 weeks, followed by active, open-label treatment through week 24 in both groups...
February 29, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38421096/peptide-drug-conjugate-with-statistically-designed-transcellular-peptide-for-psoriasis-like-inflammation
#27
JOURNAL ARTICLE
Do Hyun Bae, Hayeon Bae, Hyung-Seok Yu, Banzrach Dorsembe, Young Hyun No, Taejung Kim, Nam Hyeong Kim, Jinwoo Kim, Jiyool Kim, Bok-Soo Lee, Ye Ji Kim, Seongchan Park, Zinah Hilal Khaleel, Deok Hyang Sa, Eui-Chul Lee, Jaecheol Lee, Jungyeob Ham, Jin-Chul Kim, Yong Ho Kim
Peptide-drug conjugates (PDCs) are a promising class of drug delivery systems that utilize covalently conjugated carrier peptides with therapeutic agents. PDCs offer several advantages over traditional drug delivery systems, including enhanced target engagement, improved bioavailability, and increased cell permeability. However, the development of efficient transcellular peptides capable of effectively transporting drugs across biological barriers remains an unmet need. In this study, we employ physicochemical criteria based on cell penetrating peptides (CPPs) to design transcellular peptides derived from an antimicrobial peptides (AMPs) library...
February 29, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38399292/new-and-emerging-oral-topical-small-molecule-treatments-for-psoriasis
#28
REVIEW
Elena Carmona-Rocha, Lluís Rusiñol, Lluís Puig
The introduction of biologic therapies has led to dramatic improvements in the management of moderate-to-severe psoriasis. Even though the efficacy and safety of the newer biologic agents are difficult to match, oral administration is considered an important advantage by many patients. Current research is focused on the development of oral therapies with improved efficacy and safety compared with available alternatives, as exemplified by deucravacitinib, the first oral allosteric Tyk2 inhibitor approved for the treatment of moderate to severe psoriasis in adults...
February 6, 2024: Pharmaceutics
https://read.qxmd.com/read/38343115/vitiligo-non-responding-lesions-to-narrow-band-uvb-have-intriguing-cellular-and-molecular-abnormalities-that-may-prevent-epidermal-repigmentation
#29
JOURNAL ARTICLE
Nathaniel B Goldstein, Andrea Steel, Landon Tomb, Zachary Berk, Junxiao Hu, Velmurugan Balaya, Laura Hoaglin, Kavya Ganuthula, Meet Patel, Erica Mbika, William A Robinson, Dennis R Roop, David A Norris, Stanca A Birlea
We have discovered that human vitiligo patients treated with narrow-band UVB (NBUVB) demonstrated localized resistance to repigmentation in skin sites characterized by distinct cellular and molecular pathways. Using immunostaining studies, discovery-stage RNA-Seq analysis, and confirmatory in situ hybridization, we analyzed paired biopsies collected from vitiligo lesions that did not repigment after 6 months of NBUVB treatment (non-responding) and compared them with repigmented (responding) lesions from the same patient...
February 11, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38319157/gnas-mutation-inhibits-growth-and-induces-phosphodiesterase-4d-expression-in-colorectal-cancer-cell-lines
#30
JOURNAL ARTICLE
Pirjo Nummela, Sadia Zafar, Erika Veikkolainen, Iiris Ukkola, Vincenzo Cinella, Abiodun Ayo, Muhammad Yasir Asghar, Niko Välimäki, Kid Törnquist, Auli Karhu, Pirjo Laakkonen, Lauri A Aaltonen, Ari Ristimäki
Approximately 5% of colorectal cancers (CRCs) have a gain-of-function mutation in the GNAS gene, which leads to the activation of cAMP-dependent signaling pathways and associates with poor prognosis. We investigated the effect of an activating GNAS mutation in CRC cell lines on gene expression and cell proliferation in vitro, and tumor growth in vivo. GNAS-mutated (GNASmt) HCT116 cells showed stimulated synthesis of cAMP as compared to parental (Par) cells. The most upregulated gene in the GNASmt cells was cAMP-hydrolyzing phosphodiesterase 4D (PDE4D) as detected by RNA sequencing...
February 6, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38315652/a-study-of-roflumilast-treatment-on-functional-and-structural-changes-in-hippocampus-in-depressed-adult-male-wistar-rats
#31
JOURNAL ARTICLE
Ghida Hassan, Sherif A Kamar, Hagar Yousry Rady, Dina Sayed Abdelrahim, Nesma Hussein Abdel Hay Ibrahim, Noha N Lasheen
Depression is a common stress disability disorder that affects higher mental functions including emotion, cognition, and behavior. It may be mediated by inflammatory cytokines that interfere with neuroendocrine function, and synaptic plasticity. Therefore, reductions in inflammation might contribute to treatment response. The current study aims to evaluate the role of Protein Kinase (PKA)- cAMP response element-binding protein (CREB)- brain derived neurotropic factor (BDNF) signaling pathway in depression and the effects of roflumilast (PDE4 inhibitor) as potential antidepressant on the activity of the PKA-CREB-BDNF signaling pathway, histology, and pro-inflammatory cytokine production...
2024: PloS One
https://read.qxmd.com/read/38314722/caffeine-induced-protein-kinase-a-activation-restores-cognitive-deficits-induced-by-sleep-deprivation-by-regulating-o-glcnac-cycling-in-adult-zebrafish
#32
JOURNAL ARTICLE
Thuy-Duong Thi Tran, Jiwon Park, Dong Yeol Kim, Inn-Oc Han
Sleep deprivation (SD) is widely acknowledged as a significant risk factor for cognitive impairment. In this study, intraperitoneal caffeine administration significantly ameliorated the learning and memory (L/M) deficits induced by SD and reduced aggressive behaviors in adult zebrafish. SD led to a reduction in PKA phosphorylation, phosphorylated-cAMP response element-binding protein (p-CREB) and c-Fos expression in zebrafish brain. Notably, these alterations were effectively reversed by caffeine. Additionally, caffeine mitigated neuroinflammation induced by SD, as evident from suppression of the SD-mediated increase in GFAP and NF-κB activation...
February 5, 2024: American Journal of Physiology. Cell Physiology
https://read.qxmd.com/read/38300304/effect-of-roflumilast-a-selective-pde4-inhibitor-on-bone-phenotypes-in-ado2-mice
#33
JOURNAL ARTICLE
Imranul Alam, Sara L Hardman, Rita L Gerard-O'Riley, Dena Acton, Reginald S Parker, Jung Min Hong, Angela Bruzzaniti, Michael J Econs
Autosomal Dominant Osteopetrosis type II (ADO2) is a rare bone disease of impaired osteoclastic bone resorption that usually results from heterozygous missense mutations in the chloride channel 7 (CLCN7) gene. We previously created mouse models of ADO2 (p.G213R) with one of the most common mutations (G215R) as found in humans and demonstrated that this mutation in mice phenocopies the human disease of ADO2. Previous studies have shown that roflumilast (RF), a selective phosphodiesterase 4 (PDE4) inhibitor that regulates the cAMP pathway, can increase osteoclast activity...
February 1, 2024: Calcified Tissue International
https://read.qxmd.com/read/38283029/oral-lichen-planus-an-updated-review-of-etiopathogenesis-clinical-presentation-and-management
#34
REVIEW
Yashpal Manchanda, Sanjay K Rathi, Arun Joshi, Sudip Das
Lichen planus (LP) is a chronic idiopathic immune-mediated inflammatory condition. LP is a heterogeneous disease with varied clinical presentations having different natural history, prognosis, sequelae, and outcomes. It can affect skin, hair, nails, and mucosae. Mucosal LP (including oral LP) tends to be persistent and resistant to treatment, compared to cutaneous LP. Oral LP (OLP) is broadly divided into two main categories: hyperkeratotic (usually asymptomatic) and erosive (commonly symptomatic). It can present with symptoms including odynophagia, dysphagia, dysgeusia, and sensitivity to hot spicy foods...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38266451/the-il-4-13-induced-production-of-m2-chemokines-by-human-lung-macrophages-is-enhanced-by-adenosine-and-pge-2
#35
JOURNAL ARTICLE
Marion Brollo, Hélène Salvator, Stanislas Grassin-Delyle, Mathieu Glorion, Delphyne Descamps, Amparo Buenestado, Emmanuel Naline, Hermann Tenor, Angelica Tiotiu, Philippe Devillier
BACKGROUND AND PURPOSE: Lung macrophages (LMs) are critically involved in respiratory diseases. The primary objective of the present study was to determine whether or not an adenosine analog (NECA) and prostaglandin E2 (PGE2 ) affected the interleukin (IL)-4- and IL-13-induced release of M2a chemokines (CCL13, CCL17, CCL18, and CCL22) by human LMs. EXPERIMENTAL APPROACH: Primary macrophages isolated from resected human lungs were incubated with NECA, PGE2 , roflumilast, or vehicle and stimulated with IL-4 or IL-13 for 24 h...
January 23, 2024: International Immunopharmacology
https://read.qxmd.com/read/38258034/phosphodiesterase-4-inhibition-in-the-management-of-psoriasis
#36
REVIEW
Erika L Crowley, Melinda J Gooderham
Psoriasis is a common chronic immune-mediated disease with many comorbidities and impacts on quality of life. Among the treatments for psoriasis, phosphodiesterase-4 (PDE4) inhibitors are emerging with expanding options. PDE4 inhibitors play a pivotal role in the inflammatory cascade by degrading cyclic adenosine monophosphate (cAMP), contributing to pro-inflammatory mediator production. Apremilast, an oral PDE4 inhibitor, is approved for psoriasis. While effective, its adverse effects can limit its utility...
December 22, 2023: Pharmaceutics
https://read.qxmd.com/read/38256852/computational-molecular-docking-and-simulation-based-assessment-of-anti-inflammatory-properties-of-nyctanthes-arbor-tristis-linn-phytochemicals
#37
JOURNAL ARTICLE
Varish Ahmad, Mohammad Imran Khan, Qazi Mohammad Sajid Jamal, Faisal A Alzahrani, Raed Albiheyri
The leaves, flowers, seeds, and bark of the Nyctanthes arbor-tristis Linn plant have been pharmacologically evaluated to signify the medicinal importance traditionally described for various ailments. We evaluated the anti-inflammatory potentials of 26 natural compounds using AutoDock 4.2 and Molecular Dynamics (MDS) performed with the GROMACS tool. SwissADME evaluated ADME (adsorption, distribution, metabolism, and excretion) parameters. Arb_E and Beta-sito, natural compounds of the plant, showed significant levels of binding affinity against COX-1, COX-2, PDE4, PDE7, IL-17A, IL-17D, TNF-α, IL-1β, prostaglandin E2, and prostaglandin F synthase...
December 22, 2023: Pharmaceuticals
https://read.qxmd.com/read/38236522/hesperetin-relaxes-depolarizing-contraction-in-human-umbilical-vein-by-inhibiting-l-type-ca-2-channel
#38
JOURNAL ARTICLE
Kritsana Tipcome, Wattana B Watanapa, Katesirin Ruamyod
OBJECTIVE: To study hesperetin-induced vasorelaxation after depolarizing contraction in human umbilical veins (HUVs) to elucidate the role of L-type Ca2+ channel (LTCC) and related signaling pathway. METHODS: Isometric tension recording was performed in HUV rings pre-contracted with K+ . Hesperetin relaxing mechanism was investigated using a LTCC opener (BayK8644) and blockers of cyclic nucleotides and phosphodiesterases (PDEs). Whole-cell patch-clamping in A7r5 cells, a rat vascular smooth muscle cell line, was performed to study the effect of hesperetin on LTCC current...
January 18, 2024: Chinese Journal of Integrative Medicine
https://read.qxmd.com/read/38231072/3d-qsar-studies-on-high-affinity-phosphodiestera
#39
JOURNAL ARTICLE
Luyang Shi, Hongzong Si
BACKGROUND: Recent studies have found that Phosphodiesterase-4 (PDE4) is closely related to the pathogenesis of depression, cognitive impairment and neurological impairment. OBJECTIVE: Our objective is to develop potent inhibitors of the high-affinity phosphodiesterase 4D isoform (PDE4D) that can serve as radioligands for Positron Emission Tomography (PET) imaging, thereby advancing research in the field of neurological diseases. METHODS: We employed a multi-step approach combining three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling, molecular docking, classification techniques, and CoMSIA analysis to investigate the conformational relationship of highaffinity PDE4D inhibitors as PET ligands...
January 12, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38218008/hypersampsonone-h-attenuates-ulcerative-colitis-via-inhibition-of-pde4-and-regulation-of-camp-pka-creb-signaling-pathway
#40
JOURNAL ARTICLE
Yanzhen Li, Mingqiang Wang, Jianhui Su, Ruimin Zhong, Sheng Yin, Zhongxiang Zhao, Zhanghua Sun
BACKGROUND AND OBJECTIVES: Ulcerative colitis (UC) is a recurrent intestinal inflammatory disease which poses a serious threat to the life of patients. However, there are no specific drugs for UC yet. Hypericum sampsonii Hance (HS) is a Chinese herbal medicine traditionally used to treat enteritis and dysentery. Our previous studies have demonstrated that HS holds potential anti-UC effects, and a novel compound named Hypersampsonone H (HS-1) isolated from HS possesses significant anti-inflammatory activity...
January 12, 2024: International Immunopharmacology
keyword
keyword
29572
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.